Furness General Hospital is a hospital located in the Hawcoat area of Barrow-in-Furness, Cumbria, England. It is managed by the University Hospitals of Morecambe Bay NHS Foundation Trust.

There are 258 beds in Furness General Hospital.

During the past decade, Furness General Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Furness General Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 2 trials, followed by "Cancer Research UK" with 1 trials sponsored, "Manchester University NHS Foundation Trust" with 1 trials sponsored, "NHS Greater Glasgow and Clyde" with 1 trials sponsored and "University College, London" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Furness General Hospital" #1 collaborator was "Cancer Research UK" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator, "Northwest Research Collaborative" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Furness General Hospital" are "Ovarian Cancer" (2 trials), "Abscess Anorectal" (1 trials), "Abscess; Anus" (1 trials), "Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Furness General Hospital" in a lesser frequency.

Most popular intervention types in "Furness General Hospital" are "Drug" (6 trials), "Procedure" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "capecitabine" (2 trials), "Cediranib" (1 trials), "External dressing" (1 trials) and "Olaparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Furness General Hospital" are 5 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Furness General Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Furness General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Furness General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".